| P2093 | author name string | M M Levine | |
| | F R Noriega | |
| | S B Formal | |
| | S Ren | |
| | D R Maneval | |
| | F M Liao | |
| P2860 | cites work | Mortality due to shigellosis: community and hospital data | Q33579264 |
| | ??? | Q94264873 |
| | Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 |
| | Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin | Q33859430 |
| | Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 |
| | Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine | Q34545910 |
| | Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides | Q35335585 |
| | Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains | Q35455031 |
| | Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli | Q35460555 |
| | Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine | Q35510455 |
| | Separate resistances to arsenate and arsenite (antimonate) encoded by the arsenical resistance operon of R factor R773. | Q36290870 |
| | Isolation and composition of sheathed flagella from Bdellovibrio bacteriovorus 109J. | Q36365971 |
| | Involvement of a plasmid in the invasive ability of Shigella flexneri. | Q36437346 |
| | Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. | Q36945836 |
| | Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains | Q36989057 |
| | Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid | Q37080399 |
| | Microbiology and diagnosis of infections with Shigella and enteroinvasive Escherichia coli | Q37754318 |
| | Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 |
| | A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels | Q39512862 |
| | Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen | Q40168452 |
| | Fourteen years of shigellosis in Dhaka: an epidemiological analysis | Q43317863 |
| | An Outbreak of Dysentery Caused by Shigella dysenteriae Type 1 on a Coral Island in the Bay of Bengal | Q43877855 |
| | Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection | Q44713046 |
| | Immunogenicity of living attenuated shigellae | Q46508698 |
| | A technique for repeated collection of blood from the guinea pig | Q46913237 |
| | Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969 | Q47770578 |
| | Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 |
| | Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes | Q54601009 |
| | Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. | Q54712481 |
| | Development of vaccines against shigellosis: memorandum from a WHO meeting | Q57944882 |
| | Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | Q67941446 |
| | Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes | Q68088023 |
| | Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 |
| | Epidemic Shiga Bacillus Dysentery in Central America. II. Epidemiologic Studies in 1969 | Q69913265 |
| | The Shigella flexneri O-antigenic polysaccharide chain Nature of the biological repeating unit | Q72724968 |
| | Quantitative studies of cross reactions between Shigella flexneri types 1a, 1b, and 31 | Q73101627 |
| | Serotypes of Shigella flexneri found in children in Mexico City | Q78850199 |
| | Studies in dysentery vaccination; primary vaccination of children with polyvalent vaccines of Shigella | Q80314442 |
| | The type-specificity of immune protection against Shigella paradysenteriae (Flexner) | Q82054376 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella flexneri | Q1644417 |
| P304 | page(s) | 782-788 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Strategy for cross-protection among Shigella flexneri serotypes | |
| P478 | volume | 67 | |